- Home
- ETON vs OBT Comparison
ETON vs OBT Comparison
Compare ETON & OBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ETON | OBT |
|---|---|---|
| Founded | 2017 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.9M | 470.6M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ETON | OBT |
|---|---|---|
| Price | $16.70 | $34.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $29.67 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 216.1K | 58.8K |
| Earning Date | 03-17-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 2.06% |
| EPS Growth | N/A | ★ 34.86 |
| EPS | N/A | ★ 3.33 |
| Revenue | $70,316,000.00 | ★ $119,456,000.00 |
| Revenue This Year | $107.23 | $9.87 |
| Revenue Next Year | $29.72 | $7.66 |
| P/E Ratio | ★ N/A | $10.51 |
| Revenue Growth | ★ 102.77 | 19.42 |
| 52 Week Low | $11.09 | $20.97 |
| 52 Week High | $23.00 | $36.34 |
Technical Indicators
Market Signals| Indicator | ETON | OBT |
|---|---|---|
| Relative Strength Index (RSI) | 62.07 | 71.82 |
| Support Level | $14.49 | $29.33 |
| Resistance Level | $15.01 | $36.34 |
| Average True Range (ATR) | 0.64 | 1.08 |
| MACD | 0.19 | 0.34 |
| Stochastic Oscillator | 91.53 | 74.57 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About OBT Orange County Bancorp Inc.
Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.